Long-Term Outcomes of Different Surgical Techniques for Sacral Tarlov Cysts: A Prospective Cohort Study
A Prospective Cohort Study on the Long-Term Outcomes and Prognostic Factors of Different Surgical Techniques for the Treatment of Sacral Tarlov Cysts
1 other identifier
observational
150
0 countries
N/A
Brief Summary
Brief Summary The goal of this observational study is to evaluate the long-term outcomes of different surgical techniques for sacral Tarlov cysts in adult patients aged 18-75 years diagnosed with symptomatic sacral Tarlov cysts. The main questions it aims to answer are:
- Does one surgical technique result in better pain relief (measured by VAS score) and functional recovery (measured by JOA score) compared to others?
- How do different surgical techniques impact the long-term recurrence rate and complication rate? Researchers will compare three surgical techniques:
- Partial cyst wall resection with nerve root sleeve plasty.
- Partial cyst wall resection with nerve root sleeve reinforcement and reconstruction.
- Autologous fat/muscle with fibrin glue microscopic cyst filling.
- Undergo one of the three surgical procedures based on clinical indications.
- Complete preoperative and postoperative assessments, including pain and functional scoring, as well as MRI evaluations at baseline and during follow-up.
- Participate in a follow-up program for up to 2 years to monitor outcomes and recurrence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 24, 2024
CompletedFirst Posted
Study publicly available on registry
January 3, 2025
CompletedStudy Start
First participant enrolled
May 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
May 13, 2025
May 1, 2025
1.1 years
December 24, 2024
May 12, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Pain Reduction Assessed by Visual Analog Scale (VAS)
Baseline, 1 month, 3 months, 6 months, 12 months and 24 months postoperatively
Neurological Function Improvement Assessed by Japanese Orthopedic Association (JOA) Score
Baseline, 1 month, 3 months, 6 months, 12 months and 24 months postoperatively
Secondary Outcomes (1)
Recurrence Rate of Sacral Tarlov Cysts
12 months postoperatively and annually up to 2 years
Study Arms (3)
Partial Cyst Wall Resection with Nerve Root Sleeve Plasty
Participants in this group will undergo partial resection of the cyst wall combined with nerve root sleeve plasty. This technique involves reducing the cyst size and reconstructing the nerve root sleeve to restore nerve function and reduce symptoms.
Partial Cyst Wall Resection with Nerve Root Sleeve Reinforcement and Reconstruction
Participants in this group will undergo partial resection of the cyst wall along with reinforcement and reconstruction of the nerve root sleeve. This method provides additional structural stability to the nerve root and aims to reduce the risk of recurrence and improve postoperative outcomes.
Autologous Fat/Muscle with Fibrin Glue Microscopic Cyst Filling
Participants in this group will receive autologous fat or muscle tissue filling of the cyst cavity combined with fibrin glue sealing under microscopic guidance. This technique aims to obliterate the cyst cavity, prevent cerebrospinal fluid leakage, and enhance symptom relief and recovery.
Interventions
Surgical technique involving partial removal of the cyst wall to decompress the nerve root, followed by plasty of the nerve root sleeve to restore nerve function and prevent recurrence.
Advanced surgical technique combining partial cyst wall removal with additional reinforcement and reconstruction of the nerve root sleeve to provide enhanced support and reduce the risk of cyst recurrence.
Minimally invasive surgical technique where autologous fat or muscle tissue is used to fill the cyst cavity, and fibrin glue is applied to seal the defect, aiming to obliterate the cyst and prevent cerebrospinal fluid leakage.
Eligibility Criteria
The study population includes adult patients aged 18-75 years diagnosed with symptomatic sacral Tarlov cysts, recruited from the Department of Neurosurgery at Beijing Jishuitan Hospital. Participants must exhibit persistent symptoms such as sacral or lower back pain, neurological deficits (e.g., numbness or weakness in the lower extremities), or bowel/bladder/sexual dysfunction attributable to the cyst, confirmed by MRI. The study focuses on individuals eligible for surgical intervention without significant comorbidities or prior related surgeries. This population represents a clinically relevant cohort for evaluating the efficacy and safety of different surgical techniques for sacral Tarlov cysts.
You may qualify if:
- Age 18-75 years.
- Diagnosed with symptomatic sacral Tarlov cysts confirmed by MRI.
- Presence of at least one of the following symptoms:
- Persistent sacral or lower back pain (VAS score ≥ 4).
- Neurological deficits such as lower extremity numbness or weakness.
- Bowel, bladder, or sexual dysfunction attributable to the cyst.
- Eligible for surgical intervention based on clinical evaluation.
- Willing and able to provide written informed consent.
You may not qualify if:
- History of prior sacral Tarlov cyst surgery.
- Concurrent spinal conditions requiring separate surgical intervention.
- Active infection or systemic inflammatory disease.
- Severe comorbidities that increase surgical risk (e.g., advanced cardiac or pulmonary disease).
- Pregnancy or lactation.
- Inability to comply with follow-up requirements.
- Known allergy or contraindication to surgical materials (e.g., fibrin glue).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc, Neurosurgeon, Department of Neurosurgery, Beijing Jishuitan Hospital
Study Record Dates
First Submitted
December 24, 2024
First Posted
January 3, 2025
Study Start
May 13, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
May 13, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share